Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

100.56 +1.00 (+1.00%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Assessing Zimmer Biomet Holdings: Insights From 10 Financial Analysts
 
Via Benzinga
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
ZIMMER BIOMET HOLDINGS INC has a stellar value proposition. NYSE:ZBH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. 
Via Chartmill
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results
 
Via Benzinga
How Is The Market Feeling About Zimmer Biomet Holdings?
 
Via Benzinga
Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal
Zimmer Biomet Q1 sales rose 1.1% to $1.91 billion; FY25 EPS outlook trimmed but revenue growth forecast lifted following Paragon 28 acquisition. 
Via Benzinga
Earnings Scheduled For May 5, 2025
 
Via Benzinga
A Glimpse of Zimmer Biomet Holdings's Earnings Potential
 
Via Benzinga
What's going on in today's session: S&P500 movers
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday. 
Via Chartmill
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday?
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services... 
Via Benzinga
Why Zimmer Biomet (ZBH) Stock Is Trading Lower Today
Shares of medical device company Zimmer Biomet (NYSE:ZBH) fell 10.2% in the afternoon session after the company reported underwhelming first quarter 2025 results as it lowered its full-year EPS... 
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks have an unusual volume in today's session
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below. 
Via Chartmill
Services Activity Barely Expands In April As Price Pressures Spike To Over 2-Year Highs: 'A Worrying Backstory Is Developing'
US services sector growth slows in April. Inflationary pressures surge to a 2-year high, driven by trade tariffs. Stalling momentum and stagflation risks loom. 
Via Benzinga
Topics Economy World Trade
Which S&P500 stocks are moving on Monday?
Stay updated with the movements of the S&P500 index in the middle of the day on Monday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
Zimmer Biomet Stock Plummets On 2025 Earnings Outlook Downgrade: But Retail’s Bullish
Zimmer now expects 2025 adjusted profit per share in the range of $7.90 to $8.10, compared with its prior forecast of $8.15 to $8.35 per share. 
Via Stocktwits
Topics World Trade
Gapping S&P500 stocks in Monday's session
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
Zimmer Biomet (NYSE:ZBH) Posts Better-Than-Expected Sales In Q1
Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q1 CY2025, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per share was 2.3%... 
Via StockStory
Zimmer Biomet (ZBH) Reports Q1: Everything You Need To Know Ahead Of Earnings
Medical device company Zimmer Biomet (NYSE:ZBH) will be announcing earnings results tomorrow before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
1 Value Stock Worth Investigating and 2 to Brush Off
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
3 Healthcare Stocks Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength. 
Via Benzinga
Topics ETFs
Uncover the latest developments among S&P500 stocks in today's session.
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday. 
Via Chartmill
Which S&P500 stocks are moving on Tuesday?
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
Stocks Edge Up On Strong Bank Earnings, Netflix Soars, Dollar Rebounds: What's Driving Markets Tuesday?
Wall Street gained ground by midday trading on Tuesday, as investor concerns over the economic impact of trade tensions continued to ease following recent signs that the Trump administration was taking... 
Via Benzinga
Topics Government World Trade
What's going on in today's session: S&P500 gap up and gap down stocks
Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Is the Market Bullish or Bearish on Zimmer Biomet Holdings?
 
Via Benzinga
Price Over Earnings Overview: Zimmer Biomet Holdings
 
Via Benzinga
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q4 Earnings?
Zimmer Biomet has been treading water for the past six months, recording a small loss of 1.6% while holding steady at $101.84. However, the stock is beating the S&P 500’s 9.8% decline during that... 
Via StockStory
Topics Stocks
Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry
Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies... 
Via Benzinga
Topics Government World Trade
Indications Suggest ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) Could Be on the Verge of a Breakout.
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:ZBH Could Be on the Verge of a Breakout. Here's What You Need to Know. 
Via Chartmill
1 S&P 500 Stock with Exciting Potential and 2 to Brush Off
While the S&P 500 includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds. 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.